New partnership in Bergisch Gladbach
Stingray Healthcare (“Stingray”), a unique alliance of medical professionals, healthcare managers and entrepreneurs dedicated to advancing cancer care in Europe, is pleased to announce a new partnership with the shareholding doctors of PSBG, Praxis für Strahlentherapie Bergisch Gladbach.
Founded in 2005, PSBG is a state-of-the-art radiotherapy centre located in the Cologne area, operating across two strategic sites. Renowned for delivering advanced treatments for both malignant and benign conditions, PSBG has earned its reputation as a centre of excellence in the Rheinisch-Bergischer Kreis
Jürgen Metz, PSBG’s founding physician, stated: “Partnering with Stingray will allow us to continue to benefit from the growth while providing cutting-edge patient care and having continued access to the latest technology.”
Ralph Hefti, CEO of Stingray, added, “We are thrilled to collaborate with a medical team renowned for its quality and commitment to patients in the Rheinisch-Bergischer Kreis and beyond. This partnership further solidifies our commitment to enhancing cancer care across Europe.”
Through this majority stake acquisition, Stingray strengthens its footprint in Germany, where it has been active for over five years. With seven sites in Germany and three in France, Stingray continues to build its position as a leading European operator in cancer care.
Looking ahead, Stingray remains focused on both organic growth and strategic partnerships to expand its impact in its core markets.
